feed,title,long_url,short_url
Benzinga,Stoke Therapeutics Stock Rockets On Phase 1/2a Data: Here's Why,https://benzinga.com/general/biotech/24/03/37923355/stoke-therapeutics-stock-rockets-on-phase-12a-data-heres-why,https://da.gd/U67P
